Figure 1.
Cellular heterogeneity of MKs within the BM and of MKs present in the lung. MK subgroups within the BM. (A) Proplatelet-forming MKs close to the sinuous blood vessels are high in expression of Tubb1, Vwf,14 and MYH9.51 (B) Immunoregulatory MK subpopulation presenting MHC-II53 and CD18,58 which are responsible for the interaction with lymphocytes and neutrophils, respectively. Immunoregulatory MKs are high in expression of Chil1, Ctss,14 and CCL3,51 and secrete cytokines. (C) MKs, with suggested hematopoietic stem cell niche and osteogenic niche supporting a role evident in the high expression of Tgfb1, Egf1, COL1A3.51 (D) Subset of actively cycling MKs expressing Pola2, Pold1,14 and CCND1.50 (E) The lung contains MKs with an immunoregulatory phenotype expressing Ccr7, Hla-Drb1, and Icam1,13 in addition to intravascular MKs.69

Cellular heterogeneity of MKs within the BM and of MKs present in the lung. MK subgroups within the BM. (A) Proplatelet-forming MKs close to the sinuous blood vessels are high in expression of Tubb1, Vwf,14 and MYH9.51 (B) Immunoregulatory MK subpopulation presenting MHC-II53 and CD18,58 which are responsible for the interaction with lymphocytes and neutrophils, respectively. Immunoregulatory MKs are high in expression of Chil1, Ctss,14 and CCL3,51 and secrete cytokines. (C) MKs, with suggested hematopoietic stem cell niche and osteogenic niche supporting a role evident in the high expression of Tgfb1, Egf1, COL1A3.51 (D) Subset of actively cycling MKs expressing Pola2, Pold1,14 and CCND1.50 (E) The lung contains MKs with an immunoregulatory phenotype expressing Ccr7, Hla-Drb1, and Icam1,13 in addition to intravascular MKs.69 

Close Modal

or Create an Account

Close Modal
Close Modal